Effects of Different Exercise Training on Novel Cardio-metabolic Risk Factors in Women with Type 2 Diabetes
Oral Presentation XML
Paper ID : 1605-11THCONF
1Department of Sport Sciences, Shahrekord University, Shahrekord, Iran
2MSc of Exercise Physiology, Department of Exercise Physiology, Shahid Chamran University of Ahvaz, Ahvaz, Iran
3Department of Sport Sciences, Shahrekord University, Shahrekord, Iran.
Introduction: The purpose of this study was to examine the effects of different exercise modalities (short sprint interval training (SIT) and combined aerobic + resistance training (A+R)) on novel cardio-metabolic risk factors (triglyceride-glucose index (TyG index), triglyceride glucose-waist circumference (TyG-WC), triglyceride glucose-BMI(TyG-BMI),) in overweight women with type 2 diabetes.
Methodology: Fifty-two overweight female with type 2 diabetes (T2D) (aged 45-60 years, BMI > 30, HbA1C ≥ 6.5 %) were assigned to either SIT (n = 17), combined training (n = 17) or control groups (n = 18). Intervention consisted of SIT or combined aerobic-strength training for 10 weeks. Data were analyzed using dependent t test to compare pretest and posttest in each group. A one-way ANOVA test was used to compare the amount of changes in experimental and control training groups after 10 weeks. When ANOVA was significant, a bonferroni post hoc test was used.
Results: Considering within-group changes, there were significant improvements in TyG index (p < 0.001), TyG-BMI (p = 0.001), TyG-WC (p < 0.001), in SIT group after 10 weeks compared to baseline. In addition, there were significant changes (improvements) in TyG index (p = 0.005), TyG-BMI (p = 0.012) and TyG-WC (p < 0.001), in combined training group after 10weeks compared to baseline. However, no significant changes were observed between SIT and combined training groups after 10 weeks (p = 0.279).
Discussion: Results highlight that exercise training independent of mode of training is an effective strategy to improve some novel cardio-metabolic risk factors in women with type 2 diabetes.